UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by First Commonwealth Financial Corp PA

First Commonwealth Financial Corp PA boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,992 shares of the healthcare conglomerate’s stock after buying an additional 23 shares during the period. First Commonwealth Financial Corp PA’s holdings in UnitedHealth Group were worth $1,165,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Tealwood Asset Management Inc. purchased a new stake in UnitedHealth Group in the third quarter valued at approximately $2,905,000. Asset Planning Services Inc. LA ADV grew its position in UnitedHealth Group by 1.2% in the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after acquiring an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after purchasing an additional 3,006 shares in the last quarter. Americana Partners LLC grew its holdings in shares of UnitedHealth Group by 10.8% in the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock valued at $11,914,000 after purchasing an additional 1,984 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. lifted its holdings in UnitedHealth Group by 14.8% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock worth $5,072,000 after buying an additional 1,283 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $8.73 during trading hours on Wednesday, hitting $615.52. 222,530 shares of the company were exchanged, compared to its average volume of 3,856,671. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $566.45 billion, a price-to-earnings ratio of 39.64, a P/E/G ratio of 1.78 and a beta of 0.58. The business has a 50-day moving average of $583.53 and a 200-day moving average of $554.65. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the company posted $6.56 earnings per share. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on UNH shares. UBS Group reduced their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Stephens reduced their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Finally, Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $618.26.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.